3 Ways Genetic Counselors Provide Clarity on Eye Disease

Trained to interpret variations in your DNA, these specialists can help confirm a vision-related diagnosis and guide family members in gauging their own risk.

7:00 AM

Author | Kevin Joy

For people with inherited eye disease, genetic counselors could play an active and important role in a patient's care.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

The specialists can review an individual's DNA following a doctor's suspicion of retinitis pigmentosa, Stargardt disease or cone-rod dystrophy, among other vision-related conditions.

The goal: to identify genetic mutations and associated inheritance patterns related to the disorder.

"We consider genetic testing to be an integral part of making a diagnosis in a patient," says Kari Branham, M.S., CGC, a genetic counselor at University of Michigan Kellogg Eye Center.

The tests, which typically involve a sample of blood or saliva, also help establish whether a recipient's first-degree relatives might be at risk — and able to consider genetic testing, too.

Although a cure or treatment for a given condition may not yet be available, the findings can often guide patients toward applicable clinical trials.

And they may reveal if a person is eligible for sight-preserving gene therapy recently approved by the Food and Drug Administration.

"We want to help you feel informed, provide support and offer resources," says Kellogg genetic counselor Dana Schlegel, M.S., MPH, CGC, who, with Branham, spoke more about their role.

They work with your doctors throughout the process

Before and after a patient's diagnosis, genetic counselors are partners in care.

In the case of inherited eye disease, a patient might first speak with a Kellogg counselor to map out his or her family history to gain a better understanding of who has already been (or believed to have been) affected by a particular condition.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Then, after a doctor's thorough review, the counselor and patient will meet again.

If a diagnosis has been made, the patient will be given the option to make an informed decision about genetic testing.

That discussion includes what might happen if a test comes back positive, negative or inconclusive.

Says Branham: "If you want to fight something, you have to know what you're up against."

We consider genetic testing to be an integral part of making a diagnosis in a patient.
Kari Branham, M.S., CGC

They advise who is — and isn't — suitable for genetic testing

The first person to undergo genetic testing in the family must already be affected with the inherited eye disease. Without a doctor's diagnosis to work with, there are too many mutations to consider.

Nobody else in the family should receive the genetic test before a patient does.

SEE ALSO: Pros and Cons of Genetic Testing: What to Know Before You Go

"You have to figure out what the genetic cause is before you can move on to testing others who may be at risk or have reproductive concerns," says Branham, who notes that potentially affected family members still might choose to take no action.

"Some people may say: 'If there's no treatment, I don't want to know.'" 

In the case of inherited disease that doesn't typically present until adulthood, parents are advised to wait until a child is old enough to make their own decision about genetic testing.

But for vision problems known to affect the very young, early insight is crucial.

Genetic testing for those who don't yet have symptoms "can be something more for medical management and social support" such as receiving in-school services, Schlegel says.

They serve as a resource and provide emotional support

Learning that you have a genetic degenerative eye disease can be emotional. It also may make loved ones fear that they're susceptible, too.

That's why genetic counselors are trained not only in distilling complex information but also in addressing personal concerns of recipients and their families.

"We'll have a conversation explaining the test results — and we also will talk about recurrence risk for other members of the family," says Branham. "We'll discuss any different treatment options available and our standard of care."

SEE ALSO: Why Does the Doctor Need a Photo of My Eye?

Kellogg counselors then send patients a personalized summary letter for future reference.

Moreover, they can suggest related Michigan Medicine services that include a low-vision support group and mental health services.

And they provide a calming, knowledgeable presence throughout.

"We recognize this is a big deal, a new diagnosis that's overwhelming and life-changing and scary," Schlegel says. "So we provide the opportunity to talk it through as well."

The Retinal Dystrophy Clinic at the University of Michigan Kellogg Eye Center provides comprehensive diagnostic and management services, including genetic counseling. For more information, call 734-232-8080 or email [email protected].


More Articles About: Eye Health Kellogg Eye Center Eye Disorders genetic counseling Genetic Testing Gene Therapy Hospitals & Centers Eye Care & Vision
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
wheelchair walker image
Health Lab
Spread of drug resistant bacteria linked to patient hand contamination and antibiotic use within nursing homes
A Michigan Medicine research team seeks to identify characteristics of patients within nursing homes, as well as the nursing home environment itself, that are associated with contamination by vancomycin-resistant enterococci.
graphic drawing of colonoscopy scan with large intestine vials patient on bed doctor
Health Lab
Investment in free follow up colonoscopies will pay off
Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.
surgeons in OR with blue and teal scrubs with screen on and patient under teal sheet
Health Lab
Treating heart valve disease: What are your options?
Michigan Medicine’s head of cardiac surgery, Gorav Ailawadi, M.D, M.B.A., answers questions about different treatment options for heart valve disease.
Health Lab
How bedside musicians helped one family cope with tragedy
How the gifts of art and beside music and art programs helped one family cope with tragedy
pill bottle spilling yellow blue
Health Lab
Oral steroid usage increased across U.S., Taiwan and Denmark in past decade
Research from the University of Michigan finds that over the past decade, there has been a steady increase of oral steroids prescriptions not only in the United States, but in Taiwan and Denmark as well.